DK1076824T3 - Prænatal screening for Downs syndrom - Google Patents

Prænatal screening for Downs syndrom

Info

Publication number
DK1076824T3
DK1076824T3 DK99918188T DK99918188T DK1076824T3 DK 1076824 T3 DK1076824 T3 DK 1076824T3 DK 99918188 T DK99918188 T DK 99918188T DK 99918188 T DK99918188 T DK 99918188T DK 1076824 T3 DK1076824 T3 DK 1076824T3
Authority
DK
Denmark
Prior art keywords
marker
screening
down syndrome
syndrome
prenatal screening
Prior art date
Application number
DK99918188T
Other languages
English (en)
Inventor
Nicholas John Wald
Original Assignee
Nicholas John Wald
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26313564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1076824(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9809209.1A external-priority patent/GB9809209D0/en
Application filed by Nicholas John Wald filed Critical Nicholas John Wald
Application granted granted Critical
Publication of DK1076824T3 publication Critical patent/DK1076824T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/38Pediatrics
    • G01N2800/385Congenital anomalies
    • G01N2800/387Down syndrome; Trisomy 18; Trisomy 13
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • Y10S436/814Pregnancy
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds
    • Y10S436/817Steroids or hormones
    • Y10S436/818Human chorionic gonadotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Stereo-Broadcasting Methods (AREA)
  • Investigating Strength Of Materials By Application Of Mechanical Stress (AREA)
  • Eye Examination Apparatus (AREA)
  • For Increasing The Reliability Of Semiconductor Memories (AREA)
  • Detection And Correction Of Errors (AREA)
  • Detection And Prevention Of Errors In Transmission (AREA)
  • Monitoring And Testing Of Transmission In General (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
DK99918188T 1998-04-29 1999-04-29 Prænatal screening for Downs syndrom DK1076824T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9809209.1A GB9809209D0 (en) 1998-04-29 1998-04-29 Antenatal screening for down's syndrome
GBGB9813905.8A GB9813905D0 (en) 1998-04-29 1998-06-26 Antenatal screening for down's syndrome

Publications (1)

Publication Number Publication Date
DK1076824T3 true DK1076824T3 (da) 2006-09-18

Family

ID=26313564

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99918188T DK1076824T3 (da) 1998-04-29 1999-04-29 Prænatal screening for Downs syndrom

Country Status (11)

Country Link
US (2) US6573103B1 (da)
EP (1) EP1076824B1 (da)
AT (1) ATE330226T1 (da)
AU (1) AU763171B2 (da)
CA (1) CA2330538C (da)
DE (1) DE69931910T2 (da)
DK (1) DK1076824T3 (da)
ES (1) ES2262319T3 (da)
IL (1) IL139302A (da)
PT (1) PT1076824E (da)
WO (1) WO1999056132A1 (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627457B2 (en) 2001-07-30 2003-09-30 Quest Diagnostics Investments Incorporated Methods for detecting pregnancy
WO2003012445A1 (en) 2001-07-30 2003-02-13 Quest Diagnostics Investments Incorporated Methods and kits for detecting ita in a biological sample
JP2006510435A (ja) * 2002-12-20 2006-03-30 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 患者に対する正常な測定値を決定する方法
GB0317476D0 (en) 2003-07-25 2003-08-27 Wright David E Methods and apparatus for screening for chromosomal abnormalities
US7244233B2 (en) * 2003-07-29 2007-07-17 Ntd Laboratories, Inc. System and method for utilizing shape analysis to assess fetal abnormality
US7315787B2 (en) * 2003-10-07 2008-01-01 Ntd Laboratories, Inc. Multi-marker screening protocol for fetal abnormalities
US8700338B2 (en) 2011-01-25 2014-04-15 Ariosa Diagnosis, Inc. Risk calculation for evaluation of fetal aneuploidy
US20140342940A1 (en) 2011-01-25 2014-11-20 Ariosa Diagnostics, Inc. Detection of Target Nucleic Acids using Hybridization
US10533223B2 (en) 2010-08-06 2020-01-14 Ariosa Diagnostics, Inc. Detection of target nucleic acids using hybridization
US11031095B2 (en) 2010-08-06 2021-06-08 Ariosa Diagnostics, Inc. Assay systems for determination of fetal copy number variation
US20120034603A1 (en) 2010-08-06 2012-02-09 Tandem Diagnostics, Inc. Ligation-based detection of genetic variants
US20130261003A1 (en) 2010-08-06 2013-10-03 Ariosa Diagnostics, In. Ligation-based detection of genetic variants
US10167508B2 (en) 2010-08-06 2019-01-01 Ariosa Diagnostics, Inc. Detection of genetic abnormalities
US11203786B2 (en) 2010-08-06 2021-12-21 Ariosa Diagnostics, Inc. Detection of target nucleic acids using hybridization
US20130040375A1 (en) 2011-08-08 2013-02-14 Tandem Diagnotics, Inc. Assay systems for genetic analysis
US10131947B2 (en) 2011-01-25 2018-11-20 Ariosa Diagnostics, Inc. Noninvasive detection of fetal aneuploidy in egg donor pregnancies
WO2012103031A2 (en) 2011-01-25 2012-08-02 Ariosa Diagnostics, Inc. Detection of genetic abnormalities
US9994897B2 (en) 2013-03-08 2018-06-12 Ariosa Diagnostics, Inc. Non-invasive fetal sex determination
US8756020B2 (en) 2011-01-25 2014-06-17 Ariosa Diagnostics, Inc. Enhanced risk probabilities using biomolecule estimations
US11270781B2 (en) 2011-01-25 2022-03-08 Ariosa Diagnostics, Inc. Statistical analysis for non-invasive sex chromosome aneuploidy determination
US20130018700A1 (en) * 2011-07-14 2013-01-17 International Business Machines Corporation Optimizing product portfolios under customer choice
US8712697B2 (en) 2011-09-07 2014-04-29 Ariosa Diagnostics, Inc. Determination of copy number variations using binomial probability calculations
US10289800B2 (en) 2012-05-21 2019-05-14 Ariosa Diagnostics, Inc. Processes for calculating phased fetal genomic sequences
US10368782B2 (en) * 2012-06-09 2019-08-06 Ondine Tech Inc. Electro-medical system for neuro-muscular paralysis assessment
CN104583421A (zh) 2012-07-19 2015-04-29 阿瑞奥萨诊断公司 遗传变体的基于多重的顺序连接的检测
US20140222512A1 (en) * 2013-02-01 2014-08-07 Goodsnitch, Inc. Receiving, tracking and analyzing business intelligence data
US20140343982A1 (en) * 2013-05-14 2014-11-20 Landmark Graphics Corporation Methods and systems related to workflow mentoring
US10133996B2 (en) * 2014-04-22 2018-11-20 International Business Machines Corporation Object lifecycle analysis tool
EP2977912A1 (de) * 2014-07-25 2016-01-27 Franz-Peter Dr. Liebel Automatisierte Diagnostik
PL3189336T3 (pl) 2014-09-02 2019-07-31 Wallac Oy Sposób określania ryzyka stanu przedrzucawkowego

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874693A (en) 1986-10-10 1989-10-17 Mark Bogart Method for assessing placental dysfunction
US5506150A (en) 1987-07-09 1996-04-09 3I Research Exploitation Limited Prenatal screening for down's syndrome
EP0666477B1 (en) 1989-01-17 2003-10-15 JN Macri Technologies LLC, Inc. Apparatus for detecting Down syndrome by non-invasive maternal blood screening
US5258907A (en) 1989-01-17 1993-11-02 Macri James N Method and apparatus for detecting down syndrome by non-invasive maternal blood screening
US5316953A (en) 1989-01-17 1994-05-31 Macri James N Screening method for detecting fetal chromosal abnormalities
GB9224965D0 (en) 1992-11-28 1993-01-20 Kodak Ltd Antenatal screening for chromosomal abnormalities
GB2291059B (en) 1993-03-19 1997-09-24 North Sydney Area Health Serv Papp-a,its immunodetection and uses
GB9306354D0 (en) 1993-03-26 1993-05-19 Kodak Ltd Antenatal screening for chromosomal abnormalities
GB9410345D0 (en) 1994-05-24 1994-07-13 Univ Oxford Brookes Method of genetic testing
US5716853A (en) * 1995-07-07 1998-02-10 Chiron Diagnostics Corporation Prenatal down syndrome screening with assays specific for UGP

Also Published As

Publication number Publication date
DE69931910T2 (de) 2007-06-06
ES2262319T3 (es) 2006-11-16
IL139302A (en) 2005-07-25
DE69931910D1 (en) 2006-07-27
AU763171B2 (en) 2003-07-17
US20030175981A1 (en) 2003-09-18
EP1076824B1 (en) 2006-06-14
US6573103B1 (en) 2003-06-03
EP1076824A1 (en) 2001-02-21
IL139302A0 (en) 2001-11-25
AU3621399A (en) 1999-11-16
WO1999056132A1 (en) 1999-11-04
PT1076824E (pt) 2006-10-31
ATE330226T1 (de) 2006-07-15
CA2330538C (en) 2007-09-11
CA2330538A1 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
DK1076824T3 (da) Prænatal screening for Downs syndrom
DK0923730T3 (da) Prænatal screening for Down's syndrom ved anvendelse af hyperglykosyleret gonadotropin
ES2189799T3 (es) Metodo para detectar sindrome de down utilizando muestras de sangre seca.
GB2375111A (en) Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human fetal liver
DE69824004D1 (de) Verfahren zur quantitativen bestimmung der genexpression mit hilfe der multiplexen competitiven reversen-transkriptase polymerase kettenreaktion
DE69434867D1 (de) Gerät zur Bestimmung eines Analyten in einer Probe
ATE241139T1 (de) Vorrichtung zur durchführung eines oder mehrerer kompetitiver immunoassays
CA2022942A1 (en) Method of assessing sensitivity of hiv to zidovudine
DE69835010D1 (de) Feststellung von endometriumkrebs
DE3689490D1 (de) Elektronenstrahlprüfsonde zur Untersuchung integrierter Schaltungen.
CA2260436A1 (en) Automated method of circuit analysis
ATE136121T1 (de) Downsyndrom-screening-methode
DE69501326D1 (de) Differentielle expansion von fötalen stamzellen im mütterlichen kreislauf zur verwendung in der pränatalen genetischen analyse
ATE227024T1 (de) Verfahren und vorrichtung zur feststellung des down-syndroms durch nichtinvasive analyse von mütterlichem blut
EP1288647A3 (de) Spektroskopisches Testsystem auf Basis von Mikrokapillaren
DK0974056T3 (da) Prænatale in vitro-diagnostiske fremgangsmåder
DE69525400D1 (de) Vorgeburtliche Überprüfung von Schwangerschaftsabnormitäten
ATE329265T1 (de) Verfahren zur instrumentellen bestimmung einer sich zeitabhängig ändernden messgrösse
DE60027267D1 (de) Verfahren zur bestimmung eines erhöhten risikos einer frau, ein foetus mit dem "down-syndrom" zu tragen
WO1999054707A3 (en) Fetal testing for prediction of low birth weight
WO2021150672A3 (en) Biomarkers for placenta accreta spectrum (pas) disorders
DK0800085T3 (da) Prænatal screening for Downs Syndrom
CA2604420A1 (en) Methods of determining an increased risk of a woman carrying a downs syndrome affected fetus by measuring an analyte in a biological sample
RU98111267A (ru) Способ прогнозирования угрожающего прерывания беременности
ITRM980754A0 (it) Metodo per la misurazione di un analita in condizioni non isoterme e apparato biosensore per la sua esecuzione